Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evelo Biosciences Inc EVLO

Evelo Biosciences, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering and developing a class of oral medicines that act on immune cells in the small intestine with systemic effects. It has built a platform to discover and develop oral medicines, which target the small intestinal axis (SINTAX). Its product candidates are pharmaceutical preparations of single... see more

Recent & Breaking News (GREY:EVLO)

Evelo Biosciences Reports Second Quarter 2018 Financial Results and Recent Business Highlights

GlobeNewswire August 2, 2018

Evelo Biosciences Added To Russell 3000®, 2000® and Microcap® Indexes

GlobeNewswire June 25, 2018

Evelo Biosciences to Present at the JMP Securities 2018 Life Sciences Conference

GlobeNewswire June 14, 2018

Evelo Biosciences Reports First Quarter 2018 Financial Results and Recent Business Highlights

GlobeNewswire May 31, 2018

Evelo Biosciences Announces Closing of Initial Public Offering

GlobeNewswire May 11, 2018

Evelo Biosciences Announces Pricing of Initial Public Offering

GlobeNewswire May 8, 2018